NCT05179603 2025-12-24A Study of SAR444245 With or Without Other Anticancer Therapies for the Treatment of Adults and Adolescents With Relapsed or Refractory B Cell Lymphoma (Master Protocol) [Pegathor Lymphoma 205]SanofiPhase 2 Terminated14 enrolled 15 charts